- Home
- HRZN vs MRVI Comparison
HRZN vs MRVI Comparison
Compare HRZN & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRZN
- MRVI
- Stock Information
- Founded
- HRZN 2008
- MRVI 2014
- Country
- HRZN United States
- MRVI United States
- Employees
- HRZN N/A
- MRVI 560
- Industry
- HRZN Finance/Investors Services
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- HRZN Finance
- MRVI Health Care
- Exchange
- HRZN Nasdaq
- MRVI Nasdaq
- Market Cap
- HRZN 295.3M
- MRVI 350.1M
- IPO Year
- HRZN 2010
- MRVI 2020
- Fundamental
- Price
- HRZN $6.90
- MRVI $2.42
- Analyst Decision
- HRZN Hold
- MRVI Hold
- Analyst Count
- HRZN 4
- MRVI 10
- Target Price
- HRZN $7.81
- MRVI $5.84
- AVG Volume (30 Days)
- HRZN 684.1K
- MRVI 1.5M
- Earning Date
- HRZN 08-07-2025
- MRVI 08-11-2025
- Dividend Yield
- HRZN 19.13%
- MRVI N/A
- EPS Growth
- HRZN N/A
- MRVI N/A
- EPS
- HRZN N/A
- MRVI N/A
- Revenue
- HRZN $97,144,000.00
- MRVI $219,830,000.00
- Revenue This Year
- HRZN $0.51
- MRVI N/A
- Revenue Next Year
- HRZN $9.90
- MRVI $7.23
- P/E Ratio
- HRZN N/A
- MRVI N/A
- Revenue Growth
- HRZN N/A
- MRVI N/A
- 52 Week Low
- HRZN $6.77
- MRVI $1.67
- 52 Week High
- HRZN $11.15
- MRVI $9.60
- Technical
- Relative Strength Index (RSI)
- HRZN 30.61
- MRVI 49.60
- Support Level
- HRZN $6.86
- MRVI $2.28
- Resistance Level
- HRZN $6.96
- MRVI $2.47
- Average True Range (ATR)
- HRZN 0.09
- MRVI 0.14
- MACD
- HRZN -0.00
- MRVI -0.01
- Stochastic Oscillator
- HRZN 15.00
- MRVI 27.45
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.